Global Apheresis Market Outlook, 2029

The global apheresis market has experienced significant growth and transformation over the years, driven by advancements in medical technology and increasing demand for blood components. Apheresis, a procedure that separates and collects specific blood components while returning the remainder to the donor, has evolved since its inception in the 1970s. This growth is largely attributed to rising incidences of chronic diseases, increased platelet donations, and substantial investments in research and development by biotech firms. The apheresis market is characterized by a strong emphasis on innovation and collaboration among healthcare providers, blood banks, and technology manufacturers. The competitive landscape includes key players who are continually enhancing their product offerings through technological advancements, thereby improving the efficacy and safety of apheresis procedures. Government regulations play a crucial role in shaping the apheresis market, with initiatives aimed at promoting blood donation and ensuring the safety of blood products. For instance, World Blood Donor Day is celebrated to raise awareness about the importance of blood donation, which directly supports the apheresis process. The market include its diverse applications across various medical fields, such as oncology, neurology, and hematology, which further broadens its scope. Additionally, the rise in autoimmune diseases and haematological disorders has led to increased reliance on apheresis for effective treatment solutions. Key developments in the market include the introduction of more efficient apheresis machines and disposable kits, which enhance patient outcomes and streamline operations in healthcare settings. Overall, the global apheresis market is poised for continued growth, driven by technological advancements, increasing disease prevalence, and supportive government policies.

According to the research report, “Global Apheresis Market Outlook, 2029” published by Bonafide Research, the market is expected to reach than USD 4.50 Billion by 2023. This growth is primarily driven by the rising prevalence of chronic diseases, such as haematological disorders, autoimmune diseases, and cardiovascular diseases, which have led to an increased demand for apheresis procedures. Additionally, the surge in demand for source plasma from biopharmaceutical companies and the growing concerns regarding blood safety have further contributed to the market's expansion. Technological advancements in apheresis devices, such as the introduction of more efficient centrifugal and membrane separation technologies, have also played a significant role in enhancing the efficacy and safety of apheresis procedures, thereby driving market growth. Key players in the market, such as Fresenius Kabi and Terumo, have been actively involved in developing innovative solutions and expanding their product portfolios to cater to the increasing demand for apheresis services. Moreover, favorable reimbursement policies for apheresis procedures and the growing demand for apheresis in leukemia and pediatric patients have created attractive opportunities for market growth. However, the high cost of apheresis devices and therapeutic apheresis procedures, along with the lack of awareness regarding blood donations using apheresis, pose challenges to the market's expansion. Overall, the global apheresis market is expected to continue its upward trajectory, driven by the increasing prevalence of chronic diseases, technological advancements, and the growing demand for blood components and plasma-derived therapies.

Market Drivers

• Growing Demand for Plasma-derived Products: The increasing demand for plasma-derived products is a primary driver of the apheresis market. Plasma-derived therapies are essential for treating various medical conditions, including autoimmune disorders, hemophilia, and immunodeficiency’s. As the global population ages, the prevalence of chronic diseases is rising, leading to a higher requirement for these therapies. In 2023, plasma-derived products accounted for approximately 60% of the total apheresis market, reflecting their critical role in modern medicine. The demand is further fueled by advancements in medical treatments and a growing awareness of the efficacy of plasma therapies, prompting biopharmaceutical companies to invest in plasma collection and processing capabilities.
• Expansion of Blood Banks and Hospitals The establishment and expansion of blood banks and hospitals are significant trends impacting the apheresis market. As the demand for blood components continues to rise, there is a corresponding need for more blood collection centers and healthcare facilities equipped with apheresis technology. Blood banks and hospitals accounted for approximately 75% of the market share in 2023, driven by the increasing need for safe and effective blood products. This trend is expected to continue, with investments in healthcare infrastructure and technology enhancing the capacity and capability of these facilities to meet growing demand.

Market Challenges



• High Cost of Apheresis Devices: Despite the growing market, the high cost of apheresis devices and therapeutic procedures presents a significant challenge. The initial investment required for advanced apheresis machines can be prohibitive for smaller healthcare facilities and blood banks, limiting their ability to adopt these technologies. Moreover, the ongoing costs associated with maintenance, training, and consumables can deter potential users, especially in regions with limited healthcare budgets. This financial barrier can restrict the overall growth of the apheresis market, particularly in developing countries where healthcare infrastructure may be less robust.
• Stringent Regulations: The apheresis market is also challenged by stringent regulatory requirements that govern blood collection and processing. Regulatory bodies impose strict guidelines to ensure the safety and efficacy of blood products, which can complicate the approval process for new apheresis technologies and therapies. Compliance with these regulations often requires significant time and resources, which can hinder innovation and market entry for new players. Additionally, varying regulations across different countries can create complexities for multinational companies seeking to standardize their operations and products globally.

Market Trends
•
Increasing Adoption of Therapeutic Apheresis: Therapeutic apheresis is gaining acceptance as an effective treatment modality for various medical conditions, including autoimmune diseases, hematologic disorders, and certain infections. This trend is driven by the growing body of evidence supporting the efficacy of apheresis in managing complex medical conditions. As healthcare providers become more familiar with the benefits of therapeutic apheresis, its adoption is expected to rise, further propelling market growth. The versatility of apheresis procedures allows for tailored treatments, making them increasingly attractive to clinicians and patients alike.
• Technological Advancements: Technological innovations in apheresis equipment and procedures are significantly influencing market growth. The development of automated apheresis systems, which enhance efficiency and reduce the risk of human error, has made the collection of blood components more effective. Additionally, advancements in data analytics and integration with electronic health records (EHR) systems have improved patient management and operational efficiencies in blood banks and hospitals. These technologies not only streamline the apheresis process but also enhance the safety and quality of collected blood components, making them more appealing to healthcare providers.

Based on the report, the end user segment is distinguished into Hospitals, Blood Collection Centers and Public and Private Facilities. The Blood collection centers are leading the apheresis market due to their specialized focus on the collection, processing, and distribution of blood and blood components, which enables them to efficiently meet the rising demand for plasma and other blood products.

Blood collection centers play a pivotal role in the apheresis market by serving as dedicated facilities that optimize the collection and processing of blood components, particularly plasma. Their prominence in the market can be attributed to several key factors that enhance their operational efficiency and effectiveness. First and foremost, blood collection centers are equipped with advanced apheresis technology, including automated systems that allow for the efficient collection of multiple blood components during a single session. This capability is crucial given the increasing demand for specific blood components, such as plasma and platelets, which are essential for various therapeutic applications, including treatment for autoimmune diseases, hemophilia, and other chronic conditions. The automation of the apheresis process not only improves the speed and efficiency of blood collection but also minimizes the risk of human error, ensuring a higher level of safety for both donors and patients. Blood collection centers typically have trained personnel who specialize in apheresis procedures, further enhancing the quality of care provided. These professionals are adept at managing the complexities of the apheresis process, from donor recruitment and screening to the actual procedure and post-donation care. Their expertise ensures that the collection process is conducted smoothly and that donors are well-informed and comfortable throughout their experience. This specialized knowledge is vital in maintaining the safety and integrity of the blood products collected, which is paramount in an industry where the quality of blood components can significantly impact patient outcomes. The growing prevalence of chronic diseases and the corresponding increase in the demand for plasma-derived therapies are driving the expansion of blood collection centers. As healthcare systems worldwide grapple with rising rates of conditions such as cancer, autoimmune disorders, and cardiovascular diseases, the need for effective treatments utilizing blood components has never been greater. Blood collection centers are strategically positioned to respond to this demand, as they can rapidly scale their operations to accommodate increased collection needs. Furthermore, government initiatives aimed at promoting blood donation and raising awareness about the importance of plasma collection have bolstered the operations of these centers, encouraging more individuals to donate. Another significant factor contributing to the dominance of blood collection centers in the apheresis market is the increasing public awareness regarding the importance of blood donation. Campaigns and educational programs have successfully highlighted the critical need for blood and plasma donations, leading to a more engaged and willing donor base. This heightened awareness has resulted in a steady increase in donor turnout at collection centers, allowing them to meet the growing demand for blood products more effectively.

Based on the report, the segment is distinguished into Devices and Disposables. The apheresis devices segment leads the market due to its critical role in enabling the collection and separation of blood components, which are essential for various therapeutic applications and the growing demand for plasma-derived therapies.

Apheresis devices, which include centrifugal and membrane separation technologies, are at the heart of the apheresis market. These specialized machines play a pivotal role in separating and collecting specific blood components, such as plasma, platelets, or white blood cells, from whole blood donations. The collected components are then used in various medical treatments, including therapies for chronic diseases, autoimmune disorders, and haematological conditions. The centrifugal apheresis devices, in particular, have gained significant traction in the market due to their efficiency and effectiveness in separating blood components. These devices utilize continuous flow centrifugation technology, which allows for a smoother and more consistent separation process, leading to higher yields of desired blood components. This efficiency is crucial given the increasing demand for specific blood components, such as plasma, which is essential for the production of plasma-derived therapies. The growing prevalence of chronic diseases, such as autoimmune disorders conditions, and cardiovascular diseases, has driven the demand for these therapies, further fueling the growth of the apheresis devices segment. Technological advancements in apheresis devices have enhanced their capabilities and made them more user-friendly. The integration of automation and data analytics has streamlined the apheresis process, reducing the risk of human error and improving the overall efficiency of blood collection. These advancements have made apheresis devices more appealing to healthcare providers, who are seeking comprehensive treatment options for various conditions. The increasing adoption of therapeutic apheresis has also contributed to the dominance of the devices segment. Therapeutic apheresis is gaining acceptance as an effective treatment modality for various medical conditions, including autoimmune diseases, hematologic disorders, and certain infections. As healthcare providers become more familiar with the benefits of therapeutic apheresis, the demand for apheresis devices has risen, as these devices are essential for performing these procedures. The expansion of blood banks and hospitals, which are the primary end-users of apheresis devices, has driven the growth of this segment. The establishment or expansion of hospitals and blood collection centers has increased the demand for apheresis devices, as these facilities require advanced equipment to meet the growing need for blood components.

North America is leading the apheresis market primarily due to its advanced healthcare infrastructure, high prevalence of chronic diseases, and significant investments in research and development, which collectively create a robust environment for the growth of apheresis technologies and procedures.

The dominance of North America in the apheresis market can be attributed to several interrelated factors that enhance its capacity to meet the growing demand for blood components and plasma-derived therapies. First and foremost, the region boasts a highly developed healthcare infrastructure, characterized by state-of-the-art medical facilities, advanced technology, and a well-established network of blood collection centers. This infrastructure enables efficient blood collection and processing, ensuring that healthcare providers can rapidly respond to the increasing need for apheresis procedures. The growing elderly population, which is more susceptible to these conditions, further exacerbates this demand. Investment in research and development is another critical factor contributing to North America's leadership in the apheresis market. The region is home to numerous leading medical technology companies and research institutions that are continually innovating and improving apheresis devices and procedures. These advancements include the development of automated apheresis systems and new therapeutic applications, which enhance the efficiency and safety of apheresis. Companies such as Baxter International, Fresenius Kabi, and Haemonetics are at the forefront of these innovations, contributing to the market's growth and ensuring that North America remains a key player in the global apheresis landscape. Favorable reimbursement policies in the United States incentivize healthcare providers to adopt apheresis technologies and procedures. Insurance coverage for apheresis treatments encourages hospitals and clinics to invest in the necessary equipment and training, further driving market growth. The combination of strong financial support and a commitment to improving patient outcomes creates an environment conducive to the expansion of apheresis services. Public awareness and education regarding blood donation and the importance of apheresis also play a significant role in North America's market leadership. Campaigns aimed at increasing donor participation have successfully engaged communities, leading to higher blood donation rates. This increased supply of blood components is essential for apheresis procedures, ensuring that healthcare providers have access to the raw materials needed for effective treatments.

Considered in this report
• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in this report
• Apheresis market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Devices
• Disposables

By Application
• Renal Diseases
• Neurological Diseases
• Haematological Diseases
• Cancer
• Autoimmune Diseases
• Cardiovascular Diseases
• Others(Fibrosis, Diabetes)

By Technology
• Centrifugation
• Membrane Filtration

By End User
• Hospitals
• Blood Collection Centers
• Public and Private Facilities

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Apheresis industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.